Applied / Science K19_RESEARCH
01

RADICAL
TECHNOLOGY

We identify, develop, and de-risk high-potential intellectual property from universities to create outsized impact through acquisition or startup formation.

Core Focus

  • De-Risk Assets [01]
  • Spin-Out Startups [02]
  • Licensing [03]
CURRENT_FOCUS ONCOLOGY

University
Breakthroughs

[01]

SOURCE

Access to transformative university IP

[02]

DE-RISK

Hands-on development to reduce technical & market risk

[03]

CREATE VALUE

Position assets for acquisition or successful spin-out

[04]

IMPACT

Deliver new technologies to market faster

About Us

Bridging the gap between academic discovery and market solution.

Kingston 19 Research was founded on the belief that too many transformative ideas remain trapped in university labs due to a lack of translational resources. We serve as the experienced bridge, providing capital, scientific expertise, and industry networks to advance promising discoveries.

By strategically de-risking early-stage intellectual property, we create highly attractive assets for commercialization, ensuring that groundbreaking science fulfills its ultimate purpose: making positive societal and economic impact.

Our Approach

A disciplined model for venture creation.

01
01

Identify & Source

We actively scout leading research institutions for breakthrough technologies with strong foundational data and clear mechanistic rationale.

02
02

Develop & De-Risk

We design and execute critical killer experiments to validate the science, strengthen the IP portfolio, and map the regulatory pathway.

03
03

Partner & Spin-Out

Once de-risked, we transition assets to mature industry partners through licensing, acquisition, or by launching well-funded standalone companies.

Focus Areas

Targeting critical unmet needs.

[01]

Oncology & Immuno-oncology

[02]

Diseases Diagnostics

[03]

Neurological Disorders

[04]

Artificial Intelligence

[05]

Novel Delivery Platforms

[06]

Next-Gen Materials

Collaborate

Partner With Us

Built for collaboration.

We are seeking to engage with principal investigators, tech transfer offices, and early-stage innovators.

Universities & TTOs

We offer an alternative path to commercialization, bypassing the traditional slow VC fundraising cycle to rapidly advance your promising IP.

Principal Investigators

Keep your focus on discovery. We partner with you to handle development, strategy, and business execution.

Investors & Partners

Access a curated, rigorously de-risked pipeline of high-quality early-stage assets ready for investment or acquisition.

ACTION_REQ

Translate
Discovery

Contact us to discuss your intellectual property, partnership opportunities, or to learn more about our current portfolio of assets.

Get in Touch